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Abstract
Hereditary Angioedema (HAE) is a rare disorder caused by C1 esterase inhibitor deﬁciency or dysfunction. Patients
with HAE usually present without urticaria or pruritis affecting the skin, upper airway, or the gastrointestinal tract. They
can also present with involvement of unusual sites making the diagnosis challenging and leading to unnecessary testing
and complications. Prompt diagnosis and treatment is crucial to prevent mortality and morbidity associated with acute
ﬂare. Here we present, what is believed to be second case of isolated involvement of the jejunum from an attack of HAE.
Keywords: Hereditary angioedema, Acute abdominal pain

1. Introduction

H

ereditary Angioedema (HAE) is a rare autosomal dominant condition caused by
C1esterase inhibitor (C1INH) deﬁciency or
dysfunctional C1INH resulting in increased bradykinin and nonpitting edema of subcutaneous and
mucosal tissue in the upper respiratory and
gastrointestinal tracts.1,2 The prevalence of C1INH
deﬁciency is between 1:50,000 to 1:100,000 and that
of HAE with normal C1INH is unknown.3 To date
there is no reported disparity in HAE prevalence by
gender or ethnic groups.4 HAE can be life threatening if it involves the upper respiratory tract, and
gastrointestinal manifestations are nonspeciﬁc,
which might contribute to misdiagnoses and inappropriate surgeries.5,6
We present a case of a 33-year-old male with a
known history of HAE who presented to the emergency department (ED) with nonspeciﬁc abdominal
complaints and was found to have isolated jejunal
swelling. Although, gastrointestinal presentations are
common, based on our extensive literature review, we
believe this is the second known case of HAE with
isolated jejunal involvement [Appendix Table].

2. Case presentation
33-year-old African American male presented
with abdominal pain, nausea and vomiting for one
day. The pain was sudden in onset, initially diffuse
and later localized to the epigastric region, severe in
intensity, intermittent, crampy in nature and associated with nausea and vomiting. Patient reported
having “lumps” on the left side of his abdomen and
was concerned about the swelling. The review of
systems was positive for poor oral intake and
nausea; negative for facial or neck swelling,
dysphagia, throat/tongue swelling, respiratory
distress, or triggers for exacerbation (trauma, dental
work, unusual foods, excessive excitement, or sleep
deprivation). Past medical history was signiﬁcant for
HAE type I diagnosed in 1997 at age 10 and asthma
since childhood. He reported having 5e6 attacks of
HAE a year although previously attacks were as
high as twice per month, and typically involved the
face and neck. He had an endotracheal intubation in
his 7th grade for laryngeal attacks. Patient reported
allergy to eggs, and family history was signiﬁcant for
angioedema in maternal grandfather and paternal
grandmother. It is unknown if there is any history of
consanguineous marriage in the family.
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In the ED, patient was hemodynamically stable,
afebrile and had oxygen saturation of 98% on room
air. Clinical examination was positive for generalized abdominal tenderness to palpation, more pronounced at the left upper quadrant, but without any
peritoneal signs. Laboratory results (from a year
earlier) reported C1INH level 7 mg/dl (normal
range 21e39 mg/dl), low C1 Esterase inhibitor
function 13 (normal >67), Complement 4 serum
levels of 8 mg/dl (normal range 14e44 mg/dl)].
White blood cell count at current presentation was
12,900 per m3 (87% neutrophils without bandemia).
Computerized tomography (CT) of abdomen and
pelvis showed diffuse small bowel wall thickening
throughout the jejunum, left sided abdomen, and
moderate volume diffuse abdominopelvic free ﬂuid
(Figs. 1 and 2). The CT ﬁndings were thought to
represent abdominal manifestations of hereditary
angioedema. Patient was treated with C1INH
concentrate IV, capsaicin topical cream, haloperidol,
ketorolac, lorazepam, and ondansetron along with
1-L normal saline bolus. Following abovementioned treatment, patient showed considerable
clinical improvement and 12 h post treatment had
complete resolution of all presenting symptoms
including abdominal pain, nausea, vomiting and
leukocytosis.

Fig. 1. Diffuse small bowel wall thickening throughout the jejunum.

Fig. 2. Jejunum thickening and abdominopelvic free ﬂuid.

3. Discussion
HAE is a rare autosomal dominant disorder which
mostly is caused by a mutation in one of two alleles
for C1INH gene, leading to reduced levels of C1INH
or unfunctional C1INH. This results in complement
activation and release of bradykinin, a potent vasodilator leading to angioedema ﬂares.7 HAE is
distinct from angioedema-urticaria or histaminemediated angioedema since it does not involve
histamine and other mast cell-mediated pathway,
which explains the lack of responses of HEA to
antihistamines.8
Gastrointestinal manifestations of angioedema
can include nonspeciﬁc complaints like abdominal
pain, nausea, vomiting and diarrhea, which often
lead to misdiagnoses. In a study conducted by Bork
et al., 93.3% of patients had recurrent abdominal
symptoms.9 Diagnosis of HAE is challenging when
the patients present only with abdominal symptoms.10 CT scan as a part of investigation in such
patients showed nonspeciﬁc bowel wall thickening.
In the absence of skin ﬁndings, family history is the
most important clue that guides diagnosis. C4
complement levels serve as a screening test due to
high sensitivity and high negative predictive
values.11,12 If C4 complements levels are low,
C1INH levels and function should be checked.12
Our patient had low C4 complement/C1INH levels
and low functional activity of C1INH. We found
eight previously reported cases of HAE with
gastrointestinal manifestations involving the small
bowel. Among these, only one of them presented
with isolated jejunum involvement, and our case is
the second known case to present with an isolated
jejunum involvement. All cases are illustrated in
Appendix.
First line treatment of an acute attack includes
plasma derived C1eINH concentrate, recombinant
C1eINH, Icatibant, or Ecallantide. Fresh frozen

plasma (FFP) has been used for treatment of acute
attacks, however, considered second line treatment.
The most important intervention is patient education including identiﬁcation and avoidance of triggers to prevent acute attacks. When attacks occur,
patients should be advised to immediately go to the
ED. Long term prophylaxis management with prophylaxis include use of C1eINH concentrate, lanadelumab (monoclonal antibody to plasma
kallikrein), berotralstat (plasma kallikrein inhibitor),
danazol or tranexamic acid. Mortality is 30e50% in
untreated cases of HAE.13

4. Conclusion
HAE is a rare condition, which can present with
recurrent nonspeciﬁc abdominal manifestations.
Physicians should have high suspicion for HAE
ﬂares in patients with abdominal pain who either
have a family history or personal history of HAE.
Though gastrointestinal presentation is very common, there are not many documented cases of isolated jejunal involvement on imaging. Once a
diagnosis is made, a treatment plan should include
patient education regarding when, where, and how
to seek medical care in an acute ﬂare as C1eINH
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concentrate is not readily available at every ER. All
newly diagnosed patient should be referred to allergy and immunology clinic for long-term care
plan.
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Appendix
Table. Cases of Hereditary Angioedema involving Small Intestine.
Age in Gender Race
years

Chief Complaint

Angioedema Prior history Past Medical
of the face at of Hereditary History
presentation Angioedema

Family
History

Weinstock
et al. [1]
Courtier
et al. [2]

40

Male

No

No

Positive Jejunum

Danazol

21

Male

Recurrent episodes of
abdominal pain
Recurrent abdominal
pain, nausea and
vomiting
Abdominal pain, nausea,
vomiting and diarrhea
Abdominal pain and
loose stools

No

Yes

Positive Duodenum
and Jejunum

Danazol

No

Yes

Danazol

No

Yes

No

No

Thalassemia
carrier

Proximal and middle
small bowel
Positive Jejunum and distal ileum
edema, colo colonic
intussusception in
the splenic ﬂexure
Gastric Mucosa and
Proximal Jejunum

No

No

Irritable bowel
syndrome

No

Yes

No

Yes

LoCascio
34
et al. [3]
Diaz et al. [4] 17

Female
Female

African
American
Hispanic

Abuzakuok
et al. [5]

27

Male

Emirati

Abdominal pain

Benrajab
et al. [6]

32

Male

Caucasian Abdominal pain,
nausea and vomiting

Riguzzi
et al. [7]
Riguzzi
et al. [8]

14

Female

47

Female

Abdominal pain
and nausea
Abdominal pain
and nausea

Involved Segment

Intervention

Supportive care
with Ecallantide
and fresh frozen
plasma
C1 inhibitor
concentrate
Danazol at
discharge
Danazol

Fourth portion of the
duodenum and the
proximal jejunum
Small bowel

IV ﬂuids and FFP

Bowel wall appeared
diffusely thickened

Icatibant, discharged
on Danazol
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